 "N Rajaram, MD, Sanofi India.jpg")
Drug firm Sanofi India on Thursday said its Managing Director Rajaram Narayanan has put in his papers.
The company's board has accepted the resignation of Narayanan, effective from the close of business hours on April 10, 2022, Sanofi India said in a statement.
Narayanan has decided to pursue an opportunity outside of Sanofi, it added.
His successor will be appointed in due course, the drug firm stated.
"Under Rajaram's leadership Sanofi India has successfully implemented a variety of transformational initiatives to deliver market-beating growth in key therapies and significantly improve its overall financials," Sanofi India Chairman Aditya Narayan noted.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
